Medical Oncologist
Medicines
Zoledronic acid and denosumab cost in India: monthly and full-course price
The cost of bone-directed treatment depends on which medicine you receive, how often doses are given and for how long. Generic zoledronic acid is often less costly than denosumab, though biosimilars may narrow the gap. This page explains what makes up the total, safe ways to manage costs and questions to ask, without quoting prices.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
On this page
- What shapes the cost of zoledronic acid and denosumab in India?
- The parts that make up the total
- What to ask before you start
- The vocabulary, in plain language
- Honest points about cost and value
- When cost shapes the choice
- Sources of support to explore
- Ways to manage costs without risk
- Thinking about cost over the long term
- What people assume about cost
- Common questions about the cost of bone-directed medicines
The short answer
What shapes the cost of zoledronic acid and denosumab in India?
The cost of bone-directed treatment varies widely, and this page does not quote prices, because they change and differ between brands, suppliers and schemes. What it can do is explain the factors that shape the monthly and full-course total. The first is which medicine you receive. Zoledronic acid has been available for many years, and several generic versions are marketed in India, which generally makes it the less costly option. Denosumab is a newer antibody medicine. Its original brands tend to cost more, although biosimilar versions have been approved in India and may lower the cost. The second factor is how often doses are given. For bone metastases, denosumab is usually given every four weeks, while zoledronic acid may be given every three to four weeks or every twelve weeks, which changes the yearly total a great deal. For bone protection, both are given about every six months. The third factor is how long treatment lasts, from a few years for early breast cancer to long-term use for bone metastases. Beyond the medicine, costs include day care charges for zoledronic acid drips, blood tests of kidney function and calcium, daily calcium and vitamin D tablets, dental check-ups and occasional DEXA scans. Insurance, government schemes and employer policies differ in what they cover. Asking for a written estimate that includes all of these helps you plan.
The medicine chosen matters
Generic zoledronic acid is often less costly than denosumab.
Frequency changes the total
Four-weekly doses cost far more over a year than six-monthly ones.
Include the extras
Tests, supplements, dental checks and day care add up.
This page gives general information only. It does not quote prices or offer financing.What adds up
The parts that make up the total
The medicine is only one part of the overall cost.
The medicine
Generic zoledronic acid, original denosumab brands or denosumab biosimilars, each priced differently.
Giving the dose
Day care charges for a zoledronic acid drip, or a simpler clinic visit for a denosumab injection.
Combining with other visits can help.Tests
Kidney function and calcium before doses, vitamin D levels and occasional DEXA scans.
Supporting care
Items that are easy to forget in estimates.
Often includes
- Daily calcium and vitamin D
- Dental check-ups and treatment
- Travel for appointments
Questions to ask
What to ask before you start
Question
Why it matters
Which medicine and brand will I receive?
Generics, original brands and biosimilars differ in cost
How often will I need doses?
Frequency has the biggest effect on the yearly total
Could a longer gap between doses suit me?
Twelve-weekly zoledronic acid works well for many with bone metastases
Does the estimate include tests and day care?
These add to every dose
Will insurance cover it?
Policies differ on day care drips and injections
Words you will hear
The vocabulary, in plain language
- Generic
- A copy of a medicine sold after its patent ends, with the same active ingredient.
- Biosimilar
- A close, approved copy of a biological medicine such as denosumab.
- Original brand
- The medicine made by the company that first developed it.
- Dosing frequency
- How often doses are given, such as every four weeks or six months.
- Day care charges
- Fees for using a hospital bed or chair and nursing time for a drip.
- Pre-authorisation
- Insurer approval before treatment starts.
Being straight with you
Honest points about cost and value
It is reasonable to consider cost when choosing a bone-directed medicine, and your oncologist will understand.
Both medicines protect bone well
For bone metastases, denosumab delayed bone problems a little longer in studies, but neither helped people live longer.
A cheaper option can be a good option
Generic zoledronic acid is effective and widely used, provided your kidneys are healthy enough.
Stopping denosumab has costs too
A follow-on bisphosphonate is often needed, which should be included in planning.
What this page cannot tell you
It cannot give current prices or tell you which schemes apply. Ask the hospital's financial counsellor.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Balancing cost
When cost shapes the choice
Medical factors come first, but cost is a legitimate part of the decision.
Healthy kidneys
If kidney function is good, zoledronic acid is often a sensible, lower-cost choice.
Kidney problems
Denosumab may be preferred, and a biosimilar may reduce the cost.
Longer dosing gaps
For many people with bone metastases, twelve-weekly zoledronic acid lowers visits and costs while protecting bone well.
Talk openly
Tell your oncologist if cost is a concern before treatment starts, not after doses have lapsed.
Financial help
Sources of support to explore
Several routes may help with bone-directed treatment costs.
Health insurance
Check whether your policy covers day care drips and injections given in clinics.
Government and employer schemes
Central, state and employer schemes may include these medicines, each with their own rules.
Charities and assistance programmes
Cancer charities and manufacturer schemes sometimes help eligible patients. The hospital social worker can guide you.
Saving safely
Ways to manage costs without risk
Some ways of cutting cost are safe, and others can harm your bones.
Safe steps
Ask about approved generics or biosimilars, combine doses with other visits and check insurance cover early.
Risky steps
Letting denosumab doses lapse, buying from unverified sellers or skipping kidney tests can cause harm.
Plan ahead
Budget for the likely length of treatment and review the plan at each follow-up.
Over the years
Thinking about cost over the long term
Bone-directed treatment can continue for years, so the long-term total matters as much as the cost of a single dose.
Review the plan regularly
Ask at follow-up visits whether the dosing gap, medicine or length of treatment still makes sense for you.
Plan for stopping
If denosumab will end at some point, include the cost of follow-on treatment in your planning.
Keep receipts and records
Organised bills and prescriptions make insurance claims and scheme applications much easier.
Commonly believed
What people assume about cost
The more expensive medicine is always better.
Both protect bone well. The right choice depends on your health.
Generics and biosimilars are weaker.
Approved versions must meet standards for quality and effect.
Stopping denosumab saves money safely.
Stopping without a plan can cause rapid bone loss.
The medicine price is the full cost.
Tests, day care, supplements and dental care add to it.
Questions we are asked
Common questions about the cost of bone-directed medicines
Why does this page not give prices?
Prices change and differ between brands, generics, biosimilars and suppliers, and they depend on how often you need doses. A single figure could mislead. Ask the hospital pharmacy or billing desk for a written estimate based on your own plan.
Is zoledronic acid cheaper than denosumab?
Generally yes, because generic zoledronic acid has been available for many years. Denosumab biosimilars may narrow the gap. The total also depends on dosing frequency, day care charges and tests, so compare complete estimates rather than medicine prices alone.
Are denosumab biosimilars as good?
Approved biosimilars must show that they work and behave in the same way as the original medicine. Your team will use versions they trust. If you are switched between versions, the schedule and precautions stay the same.
Does a twelve-weekly schedule really work?
For many people with bone metastases, studies found that zoledronic acid every twelve weeks protected against bone problems about as well as more frequent doses. It is not suitable for everyone, so ask your oncologist whether it suits you.
Does insurance cover these medicines?
Many policies cover day care drips, and some cover clinic injections. Coverage varies, so check your policy wording, ask your insurer for written confirmation and involve the hospital's insurance desk early.
What if we cannot afford ongoing treatment?
Tell your oncologist. Options may include switching to generic zoledronic acid, longer dosing gaps or support schemes. If denosumab must stop, your team will plan follow-on treatment to protect your bones safely.
Are calcium and vitamin D tablets expensive?
They are usually low-cost compared with the main medicine, but they are taken daily for as long as treatment continues. Ask your team which product and dose you need, as many affordable options are available.
Should I buy the medicine online to save money?
Be cautious. Injectable medicines need proper storage, and unverified sellers may supply fake or damaged products. Use medicine sourced through your hospital or a reputable pharmacy, with a valid bill, and let your team check it.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- National Cancer Institute — Managing the cost of cancer care
- JAMA — Effect of longer-interval versus standard dosing of zoledronic acid on skeletal events in patients with bone metastases
- US Food and Drug Administration — Biosimilar and interchangeable biologics
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.